InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
67%
T+90 mean return
+3.5%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by JIMENEZ JOSEPH, Director. Director active across 2 companies, notably PROCTER & GAMBLE Co. Cumulatively, 26 filings have been recorded. History available since 8 June 2021. The latest transaction was disclosed on 11 March 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations26 total
246 shares0Common StockSEC:0001127602-25-009209:0
276 shares0Common StockSEC:0001127602-24-029120:0
1,309 shares0Common StockSEC:0001127602-24-025353:0
268 shares0Common StockSEC:0001127602-24-023765:0
284 shares0Common StockSEC:0001127602-24-018462:0
263 shares0Common StockSEC:0001127602-24-009938:0
326 shares0Common StockSEC:0001127602-23-029536:0
1,520 shares0Common StockSEC:0001127602-23-025737:0
296 shares0Common StockSEC:0001127602-23-024036:0
311 shares0Common StockSEC:0001127602-23-018694:0
287 shares0Common StockSEC:0001127602-23-010235:0
292 shares0Common StockSEC:0001127602-22-027438:0
1,610 shares0Common StockSEC:0001127602-22-023875:0
290 shares0Common StockSEC:0001127602-22-022433:0
299 shares0Common StockSEC:0001127602-22-017610:0
239 shares0Common StockSEC:0001127602-22-008761:0
253 shares0Common StockSEC:0001127602-21-031064
253 shares0Common StockSEC:0001127602-21-031064:0
1,408 shares0Common StockSEC:0001127602-21-027059:0
1,408 shares0Common StockSEC:0001127602-21-027059
241 shares0Common StockSEC:0001127602-21-025300:0
241 shares0Common StockSEC:0001127602-21-025300
49,876 shares@ US$0.3050.0% of flowCommon StockSEC:0000899243-21-027013
49,876 shares@ US$0.3050.0% of flowCommon StockSEC:0000899243-21-027013:0
260 shares0Common StockSEC:0001127602-21-019587:0
25 of 26 declarations
About JIMENEZ JOSEPH
Joseph Jimenez serves as a Board Member at Procter & Gamble Co and Graphite Bio, Inc. He brings expertise in business management and market strategy, contributing to the strategic direction of these companies. As a board member, he is involved in key decision-making processes that influence the performance of Procter & Gamble and Graphite Bio. His experience in the sector allows him to inform discussions on innovation and growth.
